InRule Technology®, an intelligence automation company providing integrated decisioning, machine learning and process automation software to the enterprise, kicks off 2023 with significant momentum after a successful 2022 fueled by new growth…
Borqs Technologies, Inc. (Nasdaq: BRQS, “Borqs”, or the “Company”), a global provider of 5G wireless and Internet of Things (IoT) solutions, today announced its plans to develop an AI-enabled smart watch as…
CalypsoAI’s independent testing and validation solution enables efficient, secure deployment of trustworthy AI. CalypsoAI, the leader in building trust in artificial intelligence (AI) through independent testing and validation, announced that it has…
QBE Insurance, a global insurer operating in 27 countries, unveiled QCyberProtect, a comprehensive and globally consistent cyber policy designed to enhance cyber resilience for a broad range of clients worldwide. QCyberProtect provides…
HGC Global Communications Limited (HGC), a fully-fledged ICT service provider and network operator with extensive global coverage, today announces the launch of Data Center Interconnect (DCI) in Bangkok. This solution is tailored to meet…
Security Compass, The Security by Design Company, today announced the launch of its SD Elements 2024.2 product release. This release expands on the platform’s industry leading AI/ML security content designed to…
Training academy aims to revolutionize learning for AI professionals to propel careers and enhance market impact Deloitte today announced the launch of the Deloitte AI Academy™ which is designed to help bridge the…
o9 Solutions, a leading enterprise AI software platform provider for transforming planning and decision-making, today reported that its annual recurring revenue (ARR) added in 2022 grew over 84% year-over-year. During Q4’22, o9…
With its AI-powered financial crime and compliance solutions, NICE Actimize offers both surveillance and anti-money laundering solutions supporting the wealth management segment NICE Actimize, a NICE (NASDAQ: NICE) business, was awarded the Best Suitability Product…
Four-year agreement with Bill & Melinda Gates Foundation to discover and develop small molecule therapeutics with less susceptibility to variants and greater patient access than current approaches Exscientia to use…
